APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Outlook and Growth Opportunities 2026

22 December 2025207 pages

Choose your research edition.

Industry ResearchPorcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market include CAHIC, Agrovet, Bioveta, Boehringer Ingelheim, CAVAC, Ceva, DHN, Komipharm and MSD Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Company

CAHIC

Agrovet

Bioveta

Boehringer Ingelheim

CAVAC

Ceva

DHN

Komipharm

MSD Animal Health

Phibro Animal Health

PULILE

Ringpu Biology

Tecon

WINSUN

ChengDu Tecbond

Sino Pharm

Jinyu Bio-Technology

Qilu Animal

Zoetis

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application

Government Tender

Market Sales

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines industry.

Chapter 3: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends Table 2. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers Table 3. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges Table 4. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Company (2021-2026) Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Company (m units) & (2021-2026) Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price (US$/k unit) of Company (2021-2026) Table 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company, Product Type & Application Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Vaccines Table 18. Significant Companies of Killed Vaccines Table 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (m units) Table 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2021-2026) & (m units) Table 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2027-2032) & (m units) Table 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Government Tender Table 30. Significant Companies of Market Sales Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (m units) Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2021-2026) & (m units) Table 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2027-2032) & (m units) Table 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Application (2021-2026) Table 35. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Application (2027-2032) Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application (2021-2026) Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application (2027-2032) Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026) & (m units) Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2027-2032) & (m units) Table 45. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2027-2032) Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Region (2021-2026) Table 49. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Region (2027-2032) Table 51. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Average Price (US$/k unit) by Region (2021-2026) Table 52. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Average Price (US$/k unit) by Region (2027-2032) Table 53. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Table 54. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 56. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2026) Table 57. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 58. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2027-2032) Table 59. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Market Share by Country (2021-2026) Table 61. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Market Share by Country (2027-2032) Table 63. CAHIC Company Information Table 64. CAHIC Business Overview Table 65. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 66. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 67. CAHIC Recent Development Table 68. Agrovet Company Information Table 69. Agrovet Business Overview Table 70. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 71. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 72. Agrovet Recent Development Table 73. Bioveta Company Information Table 74. Bioveta Business Overview Table 75. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 76. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 77. Bioveta Recent Development Table 78. Boehringer Ingelheim Company Information Table 79. Boehringer Ingelheim Business Overview Table 80. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 82. Boehringer Ingelheim Recent Development Table 83. CAVAC Company Information Table 84. CAVAC Business Overview Table 85. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 86. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 87. CAVAC Recent Development Table 88. Ceva Company Information Table 89. Ceva Business Overview Table 90. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 91. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 92. Ceva Recent Development Table 93. DHN Company Information Table 94. DHN Business Overview Table 95. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 96. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 97. DHN Recent Development Table 98. Komipharm Company Information Table 99. Komipharm Business Overview Table 100. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 101. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 102. Komipharm Recent Development Table 103. MSD Animal Health Company Information Table 104. MSD Animal Health Business Overview Table 105. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 106. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 107. MSD Animal Health Recent Development Table 108. Phibro Animal Health Company Information Table 109. Phibro Animal Health Business Overview Table 110. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 111. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 112. Phibro Animal Health Recent Development Table 113. PULILE Company Information Table 114. PULILE Business Overview Table 115. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 116. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 117. PULILE Recent Development Table 118. Ringpu Biology Company Information Table 119. Ringpu Biology Business Overview Table 120. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 121. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 122. Ringpu Biology Recent Development Table 123. Tecon Company Information Table 124. Tecon Business Overview Table 125. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 126. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 127. Tecon Recent Development Table 128. WINSUN Company Information Table 129. WINSUN Business Overview Table 130. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 131. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 132. WINSUN Recent Development Table 133. ChengDu Tecbond Company Information Table 134. ChengDu Tecbond Business Overview Table 135. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 136. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 137. ChengDu Tecbond Recent Development Table 138. Sino Pharm Company Information Table 139. Sino Pharm Business Overview Table 140. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 141. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 142. Sino Pharm Recent Development Table 143. Jinyu Bio-Technology Company Information Table 144. Jinyu Bio-Technology Business Overview Table 145. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 146. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 147. Jinyu Bio-Technology Recent Development Table 148. Qilu Animal Company Information Table 149. Qilu Animal Business Overview Table 150. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 151. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 152. Qilu Animal Recent Development Table 153. Zoetis Company Information Table 154. Zoetis Business Overview Table 155. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 156. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 157. Zoetis Recent Development Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List Table 161. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Image Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2021-2032) & (m units) Figure 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Average Price (US$/k unit) & (2021-2032) Figure 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Vaccines Image Figure 10. Killed Vaccines Image Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (m units) Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type (2021-2032) Figure 17. Government Tender Image Figure 18. Market Sales Image Figure 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (m units) Figure 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Application (2021-2032) Figure 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application (2021-2032) Figure 25. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Figure 26. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 30. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • CAHIC
  • Agrovet
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva
  • DHN
  • Komipharm
  • MSD Animal Health
  • Phibro Animal Health
  • PULILE
  • Ringpu Biology
  • Tecon
  • WINSUN
  • ChengDu Tecbond
  • Sino Pharm
  • Jinyu Bio-Technology
  • Qilu Animal
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
  1. 2.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
  2. 2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers
  3. 2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges
  4. 2.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Company
  1. 3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Product Type and Application
  8. 3.8 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Type
  1. 4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type
  5. 4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type
  9. 4.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type (2021-2032)
5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Application
  1. 5.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application
  5. 5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application
  9. 5.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2021-2032)
  11. 5.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application (2021-2032)
6 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Country, 2025 VS 2032
7 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Agrovet
  8. 8.2.1 Agrovet Company Information
  9. 8.2.2 Agrovet Business Overview
  10. 8.2.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  12. 8.2.5 Agrovet Recent Developments
  13. 8.3 Bioveta
  14. 8.3.1 Bioveta Company Information
  15. 8.3.2 Bioveta Business Overview
  16. 8.3.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  18. 8.3.5 Bioveta Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 CAVAC
  26. 8.5.1 CAVAC Company Information
  27. 8.5.2 CAVAC Business Overview
  28. 8.5.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  30. 8.5.5 CAVAC Recent Developments
  31. 8.6 Ceva
  32. 8.6.1 Ceva Company Information
  33. 8.6.2 Ceva Business Overview
  34. 8.6.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  36. 8.6.5 Ceva Recent Developments
  37. 8.7 DHN
  38. 8.7.1 DHN Company Information
  39. 8.7.2 DHN Business Overview
  40. 8.7.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  42. 8.7.5 DHN Recent Developments
  43. 8.8 Komipharm
  44. 8.8.1 Komipharm Company Information
  45. 8.8.2 Komipharm Business Overview
  46. 8.8.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  48. 8.8.5 Komipharm Recent Developments
  49. 8.9 MSD Animal Health
  50. 8.9.1 MSD Animal Health Company Information
  51. 8.9.2 MSD Animal Health Business Overview
  52. 8.9.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  54. 8.9.5 MSD Animal Health Recent Developments
  55. 8.10 Phibro Animal Health
  56. 8.10.1 Phibro Animal Health Company Information
  57. 8.10.2 Phibro Animal Health Business Overview
  58. 8.10.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  60. 8.10.5 Phibro Animal Health Recent Developments
  61. 8.11 PULILE
  62. 8.11.1 PULILE Company Information
  63. 8.11.2 PULILE Business Overview
  64. 8.11.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  66. 8.11.5 PULILE Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 Tecon
  74. 8.13.1 Tecon Company Information
  75. 8.13.2 Tecon Business Overview
  76. 8.13.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  78. 8.13.5 Tecon Recent Developments
  79. 8.14 WINSUN
  80. 8.14.1 WINSUN Company Information
  81. 8.14.2 WINSUN Business Overview
  82. 8.14.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  84. 8.14.5 WINSUN Recent Developments
  85. 8.15 ChengDu Tecbond
  86. 8.15.1 ChengDu Tecbond Company Information
  87. 8.15.2 ChengDu Tecbond Business Overview
  88. 8.15.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  90. 8.15.5 ChengDu Tecbond Recent Developments
  91. 8.16 Sino Pharm
  92. 8.16.1 Sino Pharm Company Information
  93. 8.16.2 Sino Pharm Business Overview
  94. 8.16.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  96. 8.16.5 Sino Pharm Recent Developments
  97. 8.17 Jinyu Bio-Technology
  98. 8.17.1 Jinyu Bio-Technology Company Information
  99. 8.17.2 Jinyu Bio-Technology Business Overview
  100. 8.17.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  102. 8.17.5 Jinyu Bio-Technology Recent Developments
  103. 8.18 Qilu Animal
  104. 8.18.1 Qilu Animal Company Information
  105. 8.18.2 Qilu Animal Business Overview
  106. 8.18.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  108. 8.18.5 Qilu Animal Recent Developments
  109. 8.19 Zoetis
  110. 8.19.1 Zoetis Company Information
  111. 8.19.2 Zoetis Business Overview
  112. 8.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  114. 8.19.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Analysis
  2. 9.1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Mode & Process
  6. 9.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
  9. 9.2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst